Skip to main content

Table 5 MIC50/90 distribution according to different resistance phenotypes

From: Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients

 

Cefditoren susceptible strains

Cefditoren non-susceptible strains

P

Ciprofloxacin MIC50/MIC90 (mg/L)

0.012/0.032

0.19/32

<0.001

 

Nalidixic acid susceptible strains

Nalidixic acid non-susceptible strains

P

Cefditoren MIC50/MIC90 (mg/L)

0.25/0.5

0.25/48

<0.001

 

Ciprofloxacin susceptible strains

Ciprofloxacin non-susceptible strains

P

Cefditoren MIC50/MIC90 (mg/L)

0.25/0.5

0.5/64

<0.001

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us